MANA Advisors’s Opko Health OPK Stock Holding History

MANA Advisors’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-42,400	Closed	-$103K	–	172
2019 Q2	$103K	Buy	42,400 +24,042	+131%	+$52.5K	0.23%	141
2019 Q1	$48K	Sell	18,358 -900	-5%	-$2.73K	0.16%	116
2018 Q4	$58K	Buy	+19,258	New	+$65.3K	0.37%	62
2018 Q1	–	Sell	-78,845	Closed	-$386K	–	327
2017 Q4	$386K	Buy	+78,845	New	+$457K	0.17%	226

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MANA Advisors's OPK Position: Q3 2019 in Review

MANA Advisors sold out of Opko Health (OPK) in Q3 2019, closing a stake of 42,400 shares — an estimated $103K sold.

MANA Advisors first reported a position in OPK in Q4 2017 and held it in 4 quarters. The position peaked at $386K in Q4 2017. 187 funds tracked by Wall St. Rank hold OPK as of Q3 2019.

MANA Advisors reported no remaining Opko Health position as of Q3 2019 after selling out during the quarter.
MANA Advisors sold 42,400 Opko Health shares in Q3 2019, an estimated $103K.
MANA Advisors first reported a position in Opko Health in Q4 2017 and held it in 4 quarters.
MANA Advisors's Opko Health position peaked at $386K in Q4 2017.
187 funds tracked by Wall St. Rank held Opko Health as of Q3 2019.

Based on MANA Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.